Release Date: 31/10/18 11:19 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 531.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%